IL6 and diabetic cardiomyopathy: Sullivan and collaborators hypothesize that alteration in expression in ghrelin receptor observed in diabetic cardiomyopathy could be a consequence of upregulation of inflammatory factors such as IL-1β, IL-6 [33].